Publications Employing SCi3 Resources
We'd love to highlight your wonderful work.
Did we miss your latest publication or make an error? Please let us know and we'll be sure to update our listings.
- Moses, A. et al. Monitoring of cancer ferroptosis with [18F]hGTS13, a system xc- specific radiotracer. Theranostics 15, 836-849 (2025) doi:10.7150/thno.101882. PMID: 39776801; PMID: PMC11700874.
- Wynter, C. et al. Molecular Imaging of Tumor-Infiltrating Lymphocytes in Living Animals Using a Novel mCD3 Fibronectin Scaffold. Bioconjug. Chem. 36, 104-115 (2025) doi:10.1021/acs.bioconjchem.4c00501. PMID: 39681342.
- Zhang, C. et al. Magnetic-susceptibility-dependent ratiometric probes for enhancing quantitative MRI. Nat Biomed Eng 9, 671-685 (2025) doi:10.1038/s41551-024-01286-4. PMID: 39613926.
- Shokri Varniab, Z. et al. Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy. Sci Rep 15, 13540 (2025) doi:10.1038/s41598-025-97775-w. PMID: 40253484; PMCID: PMC12009400.
1. Sen, S. et al. Biomimetic Non-ergodic Aging by Dynamic-to-covalent Transitions in Physical Hydrogels. ACS Appl Mater Interfaces 16, 32599-32610 (2024) doi:10.1021/acsami.4c03303. PMID: 38862125.
2. Atibalentja, D. F. et al. A big step for MYC-targeted therapies. Trends Cancer 10, 383-385 (2024) doi:10.1016/j.trecan.2024.03.009. PMID: 38580534.
3. Banuelos, A. et al. CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance. Proc. Natl. Acad. Sci. U.S.A. 121, e2318534121 (2024) doi:10.1073/pnas.2318534121. PMID: 38261615.
4. Morakote, W. et al. Comparison of diffusion-weighted MRI and [18F]FDG PET/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma. Eur Radiol 34, 643-653 (2024) doi:10.1007/s00330-023-10015-5. PMID: 37542653.
5. Chen, H. et al. Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma. J. Neurooncol. 170, 347-361 (2024) doi:10.1007/s11060-024-04801-4. PMID: 39180641.
6. Nernekli, K. et al. Two-Photon Intravital Microscopy of Glioblastoma in a Murine Model. J Vis Exp (2024) doi:10.3791/66304. PMID: 38497657.
7. Jeena, M. T. et al. Chaperone-Derived Copper(I)-Binding Peptide Nanofibers Disrupt Copper Homeostasis in Cancer Cells. Angew. Chem. Int. Ed. Engl. 63, e202412477 (2024) doi:10.1002/anie.202412477. PMID: 39446574.
8. Zhou, X. et al. Distortion-free water-fat separated diffusion-weighted imaging using spatiotemporal joint reconstruction. Magn Reson Med 92, 2343-2357 (2024) doi:10.1002/mrm.30221. PMID: 39051729.
9. Nguyen, H. T. M. et al. Ultrasensitive and multiplexed tracking of single cells using whole-body PET/CT. Sci Adv 10, eadk5747 (2024) doi:10.1126/sciadv.adk5747. PMID: 38875333.
10. Berman, A. et al. Additively manufactured micro-lattice dielectrics for multiaxial capacitive sensors. Sci Adv 10, eadq8866 (2024) doi:10.1126/sciadv.adq8866. PMID: 39365852.
11. Deutzmann, A. et al. Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma. Nat Commun 15, 963 (2024) doi:10.1038/s41467-024-45128-y. PMID: 38302473.
12. Lee, R. B. et al. An engineered NKp46 antibody for construction of multi-specific NK cell engagers. Protein Eng. Des. Sel. 37 (2024) doi:10.1093/protein/gzae013. PMID: 39163262; PMCID: PMC11359164.
13. Zhang, N. et al. Pyroptosis Induction with Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with PD-L1 Blockade Boosts Efficacy against Liver Cancer. Adv Healthc Mater 13, e2302606 (2024) doi:10.1002/adhm.202302606. PMID: 37987462.
14. Fowler, J. L. et al. Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells. Dev. Cell 59, 1110-1131.e22 (2024) doi:10.1016/j.devcel.2024.03.003. PMID: 38569552.
15. Yamada-Hunter, S. A. et al. Engineered CD47 protects T cells for enhanced antitumour immunity. Nature 630, 457-465 (2024) doi:10.1038/s41586-024-07443-8. PMID: 38750365.
16. Zhang, Y. et al. Corrigendum to 'Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Mouse Glioblastoma Model'. Ultrasound Med Biol 50, 455 (2024) doi:10.1016/j.ultrasmedbio.2023.12.016. PMID: 38161103.
17. Iv, M. et al. Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma. Neuroradiol J 37, 107-118 (2024) doi:10.1177/19714009231207083. PMID: 37931176.
18. Jeong, D. et al. Study of modulation in complex refractive indices induced by ultrafast relativistic electrons using infrared and THz probe pulses. Phys Med Biol 69 (2024) doi:10.1088/1361-6560/ad8832. PMID: 39419084.
19. Jeong, D. et al. Simulation of ionization charge carrier cascade time and density for a new radiation detection method based on modulation of optical properties. Med Phys 51, 1383-1395 (2024) doi:10.1002/mp.16855. PMID: 38064645.
20. Jiang, Y. et al. Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors. Nat. Biotechnol. (2024) doi:10.1038/s41587-024-02448-0. PMID: 39448881.
21. Rodencal, J. et al. Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol 31, 234-248.e13 (2024) doi:10.1016/j.chembiol.2023.10.011. PMID: 37963466; PMCID: PMC10925838.
22. Ashraf, M. R. et al. Multi-Institutional Audit of FLASH and Conventional Dosimetry With a 3D Printed Anatomically Realistic Mouse Phantom. Int. J. Radiat. Oncol. Biol. Phys. 120, 287-300 (2024) doi:10.1016/j.ijrobp.2024.03.017. PMID: 38493902.
23. Carr Delgado, H. et al. Toward "super-scintillation" with nanomaterials and nanophotonics. Nanophotonics 13, 1953-1962 (2024) doi:10.1515/nanoph-2023-0946. PMID: 38745841.
24. Das, N. et al. Increased [18F]FDG uptake of radiation-induced giant cells: a single-cell study in lung cancer models. Npj Imaging 2, 14 (2024) doi:10.1038/s44303-024-00017-3. PMID: 38912527.
25. Tirkes, T. et al. Multiparametric MRI Scoring System of the Pancreas for the Diagnosis of Chronic Pancreatitis. J Magn Reson Imaging (2024) doi:10.1002/jmri.29594. PMID: 39225586.
26. Zhang, C. et al. Magnetic-susceptibility-dependent ratiometric probes for enhancing quantitative MRI. Nat Biomed Eng (2024) doi:10.1038/s41551-024-01286-4. PMID: 39613926.
27. Galema, H. A. et al. Effects of Neoadjuvant Therapy on Tumour Target Expression of Oesophageal Cancer Tissue for NIR Fluorescence Imaging. Mol Imaging Biol 26, 955-964 (2024) doi:10.1007/s11307-024-01962-6. PMID: 39562416.
28. Neijenhuis, L. K. A. et al. Exploring the effects of taurolidine on tumor weight and microvessel density in a murine model of osteosarcoma. Oncol Res 32, 1163-1172 (2024) doi:10.32604/or.2024.050907. PMID: 38948019.
29. Roudi, R. et al. Reproducibility and repeatability of quantitative T2 and T2* mapping of osteosarcomas in a mouse model. Eur Radiol Exp 8, 74 (2024) doi:10.1186/s41747-024-00467-9. PMID: 38872042.
30. Roudi, R. et al. Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy. Invest Radiol 59, 391-403 (2024) doi:10.1097/RLI.0000000000001030. PMID: 37812494.
31. Hartmann, G. G. et al. Small Cell Lung Cancer Neuronal Features and Their Implications for Tumor Progression, Metastasis, and Therapy. Mol. Cancer Res. 22, 787-795 (2024) doi:10.1158/1541-7786.MCR-24-0265. PMID: 38912893.
32. Oser, M. G. et al. Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43, 457-469 (2024) doi:10.1038/s41388-023-02929-7. PMID: 38191672.
33. Wang, J. et al. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. Nat Commun 15, 10751 (2024) doi:10.1038/s41467-024-54761-6. PMID: 39737976.
34. Wang, J. et al. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. bioRxiv (2024) doi:10.1101/2024.01.07.574209. PMID: 38249519.
35. Skulimowska, I. et al. Polyclonal regeneration of mouse bone marrow endothelial cells after irradiative conditioning. Cell Rep 43, 114779 (2024) doi:10.1016/j.celrep.2024.114779. PMID: 39489938.
36. Wang, Y. J. et al. Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures. Cancer Cell 42, 1239-1257.e7 (2024) doi:10.1016/j.ccell.2024.06.002. PMID: 38942025.
37. Mohammed, J. et al. A common cis-regulatory variant impacts normal-range and disease-associated human facial shape through regulation of PKDCC during chondrogenesis. Elife 13, e82564 (2024) doi:10.7554/eLife.82564. PMID: 38483448.
38. Nernekli, K. et al. Two-Photon Intravital Microscopy of Glioblastoma in a Murine Model. J Vis Exp (2024) doi:10.3791/66304. PMID: 38497657.
39. Daldrup-Link, H. E. et al. Musculoskeletal imaging of senescence. Skeletal Radiol 53, 1879-1887 (2024) doi:10.1007/s00256-024-04585-8. PMID: 38329533.
40. Chen, X. et al. Antisense oligonucleotide therapeutic approach for Timothy syndrome. Nature 628, 818–825 (2024) doi:10.1038/s41586-024-07310-6. PMID: 38658687.
41. Liu, Y. et al. Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. Int J Nanomedicine 19, 2639-2653 (2024) doi:10.2147/IJN.S442143. PMID: 38500681.
42. Deutzmann, A. et al. Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma. Nat Commun 15, 963 (2024) doi:10.1038/s41467-024-45128-y. PMID: 38302473.
43. Wilson, E. N. et al. TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models. Nat Neurosci 27, 873–885 (2024) doi:10.1038/s41593-024-01610-w. PMID: 38539014.
44. Park, R. K. et al. Injectable alginate/collagen clindamycin hydrogel for treatment of surgical site infections. Sci Rep 15, 7964 (2025) doi:10.1038/s41598-025-92294-0.
45. Wang, J. et al. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. Nat Commun 15, 10751 (2024) doi:10.1038/s41467-024-54761-6. PMID: 38249519.
46. Hashemi, E. et al. A Novel Mouse Model for Cerebral Inflammatory Demyelination in X-Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets. Ann Neurol 97, 296-312 (2025) doi:10.1002/ana.27117. PMID: 39467011.
47. Lemaitre, L. et al. Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nat Cancer 5, 1534–1556 (2024) doi:10.1038/s43018-024-00828-8. PMID: 39304772.
48. Moses, A. et al. Monitoring of cancer ferroptosis with [18F]hGTS13, a system xc- specific radiotracer. Theranostics 15, 836-849 (2025) doi:10.7150/thno.101882. PMID: 39776801.
49. Wynter, C. et al. Molecular Imaging of Tumor-Infiltrating Lymphocytes in Living Animals Using a Novel mCD3 Fibronectin Scaffold. Bioconjugate Chemistry 36, 104-115 (2025) doi:10.1021/acs.bioconjchem.4c00501. PMID: 39681342
50. Mohanram, K. et al. Luciferase-Based Reporter System for Investigating GPx4-Mediated Ferroptosis and Its Therapeutic Implications in Diabetes. Analytical Chemistry 97, 1059-1069 (2025) doi:10.1021/acs.analchem.4c03065. PMID: 39579117.
51. Pandurangi, R. et al. Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. J Med Chem 67, 14200-14209 (2024) doi:10.1021/acs.jmedchem.4c01040. PMID: 39137365.
52. Zlitni, A. et al. Bridging the Translation of ICG-1-Maltotriose: A Multimodal Sensor for Monitoring and Detecting Bacterial Infections. ACS Sens 9, 2806-2814 (2024) doi:10.1021/acssensors.3c02005. PMID: 38810251.
53. Mohammed, J. et al. A common cis-regulatory variant impacts normal-range and disease-associated human facial shape through regulation of PKDCC during chondrogenesis. Elife 13, e82564 (2024) doi:10.7554/eLife.82564. PMID: 38483448.
54. Jung, K. O. et al. Single-Cell PET Imaging and Tracking. Methods Mol Biol 2729, 331-340 (2024) doi:10.1007/978-1-0716-3499-8_19. PMID: 38006505.
55. Ajenjo, J. et al. PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain. Theranostics 13, 5151-5169 (2023) doi:10.7150/thno.85549. PMID: 37908737.
56. Liu, P. et al. Sonogenetic control of multiplexed genome regulation and base editing. Nat Commun 14, 6575 (2023) doi:10.1038/s41467-023-42249-8. PMID: 37852951.
- Chaney, A. M. et al. PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis. Sci Transl Med 15, eabm6267 (2023) doi:10.1126/scitranslmed.abm6267. PMID: 37379371.
- Faucher, F. F. et al. Protease Activated Probes for Real-Time Ratiometric Imaging of Solid Tumors. ACS Cent. Sci. 9, 1059–1069 (2023) doi:10.1021/acscentsci.3c00261. PMID: 37252358.
- Wu, Y. et al. Kinase-Modulated Bioluminescent Indicators Enable Noninvasive Imaging of Drug Activity in the Brain. ACS Cent Sci 9, 719-732 (2023) doi:10.1021/acscentsci.3c00074. PMID: 37122464.
- Zengel, J. et al. Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression. Nat Methods 20, 1070-1081 (2023) doi:10.1038/s41592-023-01896-x. PMID: 37291262.
- Wu, W. E. et al. Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models. Invest Radiol 58, 388-395 (2023) doi:10.1097/RLI.0000000000000946. PMID: 36729074.
- Ajenjo, J. et al. PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain. Theranostics 13, 5151-5169 (2023) doi:10.7150/thno.85549. PMID: 37908737.
- Reyes, S. T. et al. Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography. J Vis Exp (2023) doi:10.3791/64133. PMID: 36744792.
- Kalita, M. et al. PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84. JACS Au 3, 3297-3310 (2023) doi:10.1021/jacsau.3c00435. PMID: 38155640.
- Schneider, M. K. et al. Combined near infrared photoacoustic imaging and ultrasound detects vulnerable atherosclerotic plaque. medRxiv [Preprint] (2023) doi:10.1101/2023.06.11.23291099. PMID: 37398016.
- Natarajan, A. et al. Preclinical Evaluation of 89Zr-Panitumumab for Biology-Guided Radiation Therapy. Int J Radiat Oncol Biol Phys 116, 927-934 (2023) doi:10.1016/j.ijrobp.2023.01.007. PMID: 36669541.
- Huang, C. H. et al. Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy. Theranostics 13, 1745-1758 (2023) doi:10.7150/thno.79342. PMID: 37064879.
- Hajfathalian, M. et al. Theranostic gold-in-gold cage nanoparticles enable photothermal ablation and photoacoustic imaging in biofilm-associated infection models. J Clin Invest 133, e168485 (2023) doi:10.1172/JCI168485. PMID: 37651187.
- Menzel, M. et al. Using light and X-ray scattering to untangle complex neuronal orientations and validate diffusion MRI. Elife 12, e84024 (2023) doi:10.7554/eLife.84024. PMID: 37166005.
- Puzzo, F. et al. Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer. Mol Ther Nucleic Acids 31, 383-397 (2023) doi:10.1016/j.omtn.2023.01.007. PMID: 36817723.
- Lin, S. et al. An osteoinductive and biodegradable intramedullary implant accelerates bone healing and mitigates complications of bone transport in male rats. Nat Commun 14, 4455 (2023) doi:10.1038/s41467-023-40149-5. PMID: 37488113.
1. Agudelo, JP. et al. Multiparametric Magnetic Resonance Imaging and Metabolic Characterization of Patient-Derived Xenograft Models of Clear Cell Renal Cell Carcinoma. Metabolites. 2022 NOV 15; 12(11). DOI: 10.3390/metabo12111117. 2022 Nov 15. PMID: 36422257.
2. Theruvath, J. et al. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nat. Med. 2022 FEB 01; 28(2):333-344. DOI: 10.1038/s41591-021-01625-x. 2022 Jan 13. PMID: 35027753.
3. Nishiga, Y. et al. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer. 2022 NOV 01; 3(11):1351-1366. DOI: 10.1038/s43018-022-00456-0. 2022 Nov 21. PMID: 36411318.
4. Groves, SM. et al. Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer. Cell Syst. 2022 SEP 21; 13(9):690-710.e17. DOI: 10.1016/j.cels.2022.07.006. 2022 Aug 17. PMID: 35981544.
5. Rovira-Clavé, X. et al. Spatial epitope barcoding reveals clonal tumor patch behaviors. Cancer Cell. 2022 NOV 14; 40(11):1423-1439.e11. DOI: 10.1016/j.ccell.2022.09.014. 2022 Oct 13. PMID: 36240778.
6. Becker, WR. et al. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nat. Genet. 2022 JUL 01; 54(7):985-995. DOI: 10.1038/s41588-022-01088-x. 2022 Jun 20. PMID: 35726067.
7. Raj, N. et al. The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Mol. Cell. 2022 JUL 07; 82(13):2370-2384.e10. DOI: 10.1016/j.molcel.2022.04.010. 2022 May 4. PMID: 35512709.
8. Grosskopf, AK. et al. Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors. Sci Adv. 2022 APR 08; 8(14):eabn8264. DOI: 10.1126/sciadv.abn8264. 2022 Apr 8. PMID: 35394838.
9. Kim, JW. et al. DLL3 regulates Notch signaling in small cell lung cancer. iScience. 2022 DEC 22; 25(12):105603. DOI: 10.1016/j.isci.2022.105603. 2022 Nov 16. PMID: 36483011.
10. Chen M. et al. In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy. Cell Chem Biol. 2022 OCT 20; 29(10):1556-1567.e6. DOI: 10.1016/j.chembiol.2022.08.006. 2022 Sep 13. PMID: 36103874.
11. Pérez-Cruz, M. et al. Immunoregulatory effects of RGMb in gut inflammation. Front Immunol. 2022 JAN 01; 13:960329. DOI: 10.3389/fimmu.2022.960329. 2022 Nov 7. PMID: 36420263.
12. Xie, J. et al. Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies. ACS Cent Sci. 2022 MAY 25; 8(5):590-602. DOI: 10.1021/acscentsci.2c00142. 2022 May 12. PMID: 35647285.
13. Kheirolomoom, A. et al. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials. 2022 FEB 01; 281:121339. DOI: 10.1016/j.biomaterials.2021.121339. 2021 Dec 29. PMID: 35078042.
14. Freitas, KA. et al. Enhanced T cell effector activity by targeting the Mediator kinase module. Science. 2022 NOV 11; 378(6620):eabn5647. DOI: 10.1126/science.abn5647. 2022 Nov 11. PMID: 36356142.
15. Foster, DS. et al. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022 NOV 14; 40(11):1392-1406.e7. DOI: 10.1016/j.ccell.2022.09.015. 2022 Oct 20. PMID: 36270275.
16. Xiao, Z. et al. ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD. Blood Adv. 2022 AUG 23; 6(16):4782-4792. DOI: 10.1182/bloodadvances.2022007403. PMID: 35790103.
17. Wang, H. et al. Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma. Nanotheranostics. 2022 JAN 01; 6(1):62-78. DOI: 10.7150/ntno.63320. 2022 Jan 1. PMID: 34976581.
18. Jung, KO. et al. Mechanoporation enables rapid and efficient radiolabeling of stem cells for PET imaging. Sci Rep. 2022 FEB 22; 12(1):2955. DOI: 10.1038/s41598-022-06938-6. 2022 Feb 22. PMID: 35194089.
19. Liu, Y. et al. Inhaled Gold Nano-star Carriers for Targeted Delivery of Triple Suicide Gene Therapy and Therapeutic MicroRNAs to Lung Metastases: Development and Validation in a Small Animal Model. Adv Ther (Weinh). 2022 AUG 01; 5(8). DOI: 10.1002/adtp.202200018. 2022 Jun 17. PMID: 36212523.
20. Sadeghipour, N. et al. A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models. Sci Rep. 2022 JUL 14; 12(1):12017. DOI: 10.1038/s41598-022-16219-x. 2022 Jul 14. PMID: 35835978.
21. Kim, SB. et al. Compact Eight-Channel Light-Sensing System for Bioassays. Methods Mol. Biol. 2022 JAN 01; 2525:377-386. DOI: 10.1007/978-1-0716-2473-9_29. PMID: 35836084.
22. Rice, MA. et al. SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer. Cell Rep Med. 2022 FEB 15; 3(2):100502. DOI: 10.1016/j.xcrm.2021.100502. 2022 Feb 2. PMID: 35243415.
23. Vetrik, M. et al. Fluorinated diselenide nanoparticles for radiosensitizing therapy of cancer. Free Radic Biol Med. 2022 JUL 01; 187:132-140. DOI: 10.1016/j.freeradbiomed.2022.05.015. 2022 May 24. PMID: 35618181.
24. Kar, S. et al. Label-free discrimination of tumorigenesis stages using in vitro prostate cancer bone metastasis model by Raman imaging. Sci Rep. 2022 MAY 16; 12(1):8050. DOI: 10.1038/s41598-022-11800-w. 2022 May 16. PMID: 35577856.
25. Paulmurugan, R. et al. BRET Sensors for Imaging Membrane Integrity of Microfluidically Generated Extracellular Vesicles. Methods Mol. Biol. 2022 JAN 01; 2525:227-238. DOI: 10.1007/978-1-0716-2473-9_17. PMID: 35836072.
26. Kumar, US. et al. FN3 linked nanobubbles as a targeted contrast agent for US imaging of cancer-associated human PD-L1. J Control Release. 2022 JUN 01; 346:317-327. DOI: 10.1016/j.jconrel.2022.04.030. 2022 Apr 29. PMID: 35469983.
27. Meyer, E. et al. CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies. Clin Lymphoma Myeloma Leuk. 2022 OCT 01; 22 Suppl 2:S447. DOI: 10.1016/S2152-2650(22)01672-X. PMID: 36164225.
28. Jugniot, N. et al. Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging. J Nanobiotechnology. 2022 JUN 10; 20(1):267. DOI: 10.1186/s12951-022-01484-9. 2022 Jun 10. PMID: 35689262.
29. Mohammadjavadi, M. et al. Transcranial ultrasound neuromodulation of the thalamic visual pathway in a large animal model and the dose-response relationship with MR-ARFI. Sci Rep. 2022 NOV 15; 12(1):19588. DOI: 10.1038/s41598-022-20554-4. 2022 Nov 15. PMID: 36379960.
30. Li, N. et al. Improving in situ acoustic intensity estimates using MR acoustic radiation force imaging in combination with multifrequency MR elastography. Magn Reson Med. 2022 OCT 01; 88(4):1673-1689. DOI: 10.1002/mrm.29309. 2022 Jun 28. PMID: 35762849.
31. Wu, A. et al. Updates in intraoperative strategies for enhancing intra-axial brain tumor control. Neuro-oncology. 2022 NOV 02; 24(Suppl 6):S33-S41. DOI: 10.1093/neuonc/noac170. PMID: 36322098.
32. Liu, C. et al. Reversibly Photoswitching Upconversion Nanoparticles for Super-Sensitive Photoacoustic Molecular Imaging. Angew. Chem. Int. Ed. Engl. 2022 MAY 02; 61(19):e202116802. DOI: 10.1002/anie.202116802. 2022 Feb 24. PMID: 35139242.
33. Panditharatna, E. et al. BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma. Cancer Discov. 2022 DEC 02; 12(12):2880-2905. DOI: 10.1158/2159-8290.CD-21-1491. PMID: 36305736.
34. Shi, H. et al. NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC Med Chem. 2022 JAN 27; 13(1):90-97. DOI: 10.1039/d1md00313e. 2021 Nov 23. PMID: 35224499.
35. Bose, RJ. et al. Engineered Cell-Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple-Negative Breast Cancer in Mice. Adv Healthc Mater. 2022 MAR 01; 11(5):e2101387. DOI: 10.1002/adhm.202101387. 2021 Dec 17. PMID: 34879180.
36. Ha, B. et al. Real-time optical oximetry during FLASH radiotherapy using a phosphorescent nanoprobe. Radiother Oncol. 2022 NOV 01; 176:239-243. DOI: 10.1016/j.radonc.2022.08.011. 2022 Aug 11. PMID: 35964762.
37. Duan, H. et al. Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer. J. Nucl. Med. 2022 DEC 01; 63(12):1829-1835. DOI: 10.2967/jnumed.122.263971. 2022 May 12. PMID: 35552245.
38. Eke, I. et al. Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. Sci Rep. 2022 MAR 03; 12(1):3500. DOI: 10.1038/s41598-022-07394-y. 2022 Mar 3. PMID: 35241721.
39. Jugniot, N. et al. Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy. J Exp Clin Cancer Res. 2022 OCT 12; 41(1):299. DOI: 10.1186/s13046-022-02501-3. 2022 Oct 12. PMID: 36224614.
40. Lazow, MA. et al. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Neuro-oncology. 2022 MAY 04; 24(5):821-833. DOI: 10.1093/neuonc/noab245. PMID: 34668975.
41. Chen, W. et al. Alternative medicine: therapeutic effects on gastric original signet ring carcinoma via ascorbate and combination with sodium alpha lipoate. BMC Complement Med Ther. 2022 MAR 07; 22(1):58. DOI: 10.1186/s12906-022-03541-0. 2022 Mar 7. PMID: 35255889.
42. Lange, JT. et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat. Genet. 2022 OCT 01; 54(10):1527-1533. DOI: 10.1038/s41588-022-01177-x. 2022 Sep 19. PMID: 36123406.
43. Miller, JA. et al. De-escalating elective nodal irradiation for nasopharyngeal carcinoma. Lancet Oncol. 2022 APR 01; 23(4):441-443. DOI: 10.1016/S1470-2045(22)00096-1. 2022 Feb 28. PMID: 35240054.
44. Hu, Z. et al. Detection and Characterization of Sentinel Lymph Node by Ultrasound Molecular Imaging with B7-H3-Targeted Microbubbles in Orthotopic Breast Cancer Model in Mice. Mol Imaging Biol. 2022 APR 01; 24(2):333-340. DOI: 10.1007/s11307-021-01680-3. 2021 Nov 17. PMID: 34787812.
45. Lu, DJ. et al. Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931. Int. J. Radiat. Oncol. Biol. Phys. 2022 JUL 15; 113(4):787-795. DOI: 10.1016/j.ijrobp.2022.03.033. 2022 Apr 6. PMID: 35395358.
46. Afjei, R. et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers (Basel). 2022 DEC 12; 14(24). DOI: 10.3390/cancers14246120. 2022 Dec 12. PMID: 36551609.
47. Kiru, L. et al. In vivo imaging of nanoparticle-labeled CAR T cells. Proc. Natl. Acad. Sci. U.S.A. 2022 FEB 08; 119(6). DOI: 10.1073/pnas.2102363119. PMID: 35101971.
48. Liang, EC. et al. Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era. Transplant Cell Ther. 2022 AUG 01; 28(8):490-495. DOI: 10.1016/j.jtct.2022.05.010. 2022 May 15. PMID: 35584783.
1. Chen M. et al. [18F]-C-SNAT4: an improved caspase-3-sensitive nanoaggregation PET tracer for imaging of tumor responses to chemo- and immunotherapies. Eur. J. Nucl. Med. Mol. Imaging. 2021 OCT 01; 48(11):3386-3399. DOI: 10.1007/s00259-021-05297-0. 2021 Mar 13. PMID: 33712870.
2. Chen, YS. et al. Ultra-high-frequency radio-frequency acoustic molecular imaging with saline nanodroplets in living subjects. Nat Nanotechnol. 2021 JUN 01; 16(6):717-724. DOI: 10.1038/s41565-021-00869-5. 2021 Mar 29. PMID: 33782588.
3. Vences-Catalán, F. et al. Targeting the tetraspanin CD81 reduces cancer invasion and metastasis. Proc. Natl. Acad. Sci. U.S.A. 2021 JUN 15; 118(24). DOI: 10.1073/pnas.2018961118. PMID: 34099563.
4. Pandurangi, RS, et al. A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment. PLoS ONE. 2021 JAN 01; 16(2):e0225869. DOI: 10.1371/journal.pone.0225869. 2021 Feb 8. PMID: 33556062.
5. Neumann, PR. et al. Different PEG-PLGA Matrices Influence In Vivo Optical/Photoacoustic Imaging Performance and Biodistribution of NIR-Emitting π-Conjugated Polymer Contrast Agents. Adv Healthc Mater. 2021 FEB 01; 10(4):e2001089. DOI: 10.1002/adhm.202001089. 2020 Aug 31. PMID: 32864903.
6. Robinson, ER. et al. Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy. J Control Release. 2021 JUL 10; 335:281-289. DOI: 10.1016/j.jconrel.2021.05.026. 2021 May 21. PMID: 34029631.
7. Tailor, D. et al. Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer. Cell Chem Biol. 2021 AUG 19; 28(8):1206-1220.e6. DOI: 10.1016/j.chembiol.2021.02.014. 2021 Mar 12. PMID: 33713600.
8. Zhou, Q. et al. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma. Sci Rep. 2021 MAR 11; 11(1):5710. DOI: 10.1038/s41598-021-84831-4. 2021 Mar 11. PMID: 33707521.
9. Cui, L. et al. Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat. Biotechnol. 2021 MAR 01; 39(3):357-367. DOI: 10.1038/s41587-020-0707-9. 2020 Oct 19. PMID: 33077961.
10. Aghevlian, S. et al. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice. Nucl Med Biol. 2021 JAN 01; 98-99:8-17. DOI: 10.1016/j.nucmedbio.2021.04.001. 2021 Apr 21. PMID: 33962357.
11. Hirai, T. et al. Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance. J. Clin. Invest. 2021 APR 15; 131(8). DOI: 10.1172/JCI139991. PMID: 33855972.
12. Xie, J. et al. In Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification. Cancer Res. 2021 MAY 01; 81(9):2510-2521. DOI: 10.1158/0008-5472.CAN-20-2969. 2021 Feb 26. PMID: 33637565.
13. Hirai, T. et al. Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. Blood Adv. 2021 JUN 08; 5(11):2528-2538. DOI: 10.1182/bloodadvances.2020003272. PMID: 34100904.
14. Simonetta, F. et al. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET. Clin. Cancer Res. 2021 FEB 15; 27(4):1058-1068. DOI: 10.1158/1078-0432.CCR-20-2770. 2020 Oct 21. PMID: 33087332.
15. Doan, A. et al. RB depletion is required for the continuous growth of tumors initiated by loss of RB. PLoS Genet. 2021 DEC 01; 17(12):e1009941. DOI: 10.1371/journal.pgen.1009941. 2021 Dec 8. PMID: 34879057.